2018
DOI: 10.1016/j.cca.2018.02.010
|View full text |Cite
|
Sign up to set email alerts
|

The erythrocyte osmotic resistance test as screening tool for cholesterol-related lysosomal storage diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…The evaluation of erythrocyte osmotic stability is very important for the study of these cells [19][20][21][22][23][24][25] and constitutes a relevant clinical tool, not only for the characterization of erythrocytopathies, but also for the study of several diseases, such as type 1 diabetes, 26 malaria and pre-eclampsia 27,28 and clinical interventions such as bariatric surgery 29 and physical exercise 30 among other situations that may affect red blood cells.…”
mentioning
confidence: 99%
“…The evaluation of erythrocyte osmotic stability is very important for the study of these cells [19][20][21][22][23][24][25] and constitutes a relevant clinical tool, not only for the characterization of erythrocytopathies, but also for the study of several diseases, such as type 1 diabetes, 26 malaria and pre-eclampsia 27,28 and clinical interventions such as bariatric surgery 29 and physical exercise 30 among other situations that may affect red blood cells.…”
mentioning
confidence: 99%
“…Thus, patients with NPA and NPB can be diagnosed with acid sphingomyelinase (ASM) de ciency. NPD type C (NPD-C1, MIM257220; or NPD-C2, MIM601015) results from a defect in the transport of low-density lipoprotein cholesterol in cells (3,4). Type D is also known as Nova Scotia NPD; some cases are an allelic variant of NPD-C1 (5).…”
Section: Introductionmentioning
confidence: 99%